Frequency News and Research

RSS

Molecular subtyping can predict chemotherapy benefit in patients with colorectal cancer

Molecular subtyping can help predict outcomes and chemotherapy benefit in patients with colorectal cancer, according to a presentation at the annual conference of the American Society of Clinical Oncology (ASCO).

6 Jun 2013

Solid formulations of the recombinant anthrax vaccine: an interview with Dr Mark Carnegie-Brown, CEO, Glide Pharma

Anthrax vaccines have a prominent place in the history of medicine. This goes back to, Pasteur, who while everybody associates with the milk treatment process, also worked on rabies and Anthrax vaccines in cattle.

6 Jun 2013

Zalicus advancing Z944 into further clinical development

Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today announced that it is advancing Z944, its novel oral T-type calcium channel blocker, into further clinical development in the third quarter of 2013.

4 Jun 2013

PCORI awards $2.1M to USF college of nursing to study a new approach for cancer management

The Patient-Centered Outcomes Research Institute (PCORI) has approved a $2.1-million award to the University of South Florida College of Nursing to study "Patient Outcomes of a Self-care Management Approach to Cancer Symptoms: A Clinical Trial." USF Distinguished Professor and Thompson Professor of Oncology Nursing Susan C. McMillan, PhD, ARNP, FAAN, will lead the research project.

4 Jun 2013

Experts from ProfNet are available to discuss hurricane preparedness and response

With hurricane season on its way, here are experts from the ProfNet network that are available to discuss hurricane preparedness and response for consumers and businesses. If you are interested in interviewing any of the experts, please contact them via the contact information at the end of the listing.

1 Jun 2013

Twitter: A popular source for receiving and sharing new information about vaccines

Twitter is a popular source for receiving and sharing new information about vaccines, and also a basically reliable one, according to a study published in the June issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).

1 Jun 2013

UB researchers are developing a network of wireless body sensors

The military has for decades used sonar for underwater communication. Now, researchers at the University at Buffalo are developing a miniaturized version of the same technology to be applied inside the human body to treat diseases such as diabetes and heart failure in real time.

1 Jun 2013

Fatigue and sleep have predictive value for sports performance

Two new studies show that fatigue may impair strike-zone judgment during the 162 game Major League Baseball season, and a MLB player's sleepiness can predict his longevity in the league.

1 Jun 2013

Surgeons use MarginProbe System to cut out breast cancer cells missed during initial lumpectomy

Any breast cancer surgeon who regularly performs lumpectomies confronts the question "Did I get it all?" Thirty to 60 percent of the time in the U.S., the answer is "no," requiring the patient to undergo a second surgery to remove the remaining tumor.

1 Jun 2013

New avatar system could provide quick and effective therapy for schizophrenia

An avatar system that enables people with schizophrenia to control the voice of their hallucinations is being developed by researchers at UCL with support from the Wellcome Trust.

31 May 2013

Discovery opens doors to new therapies for sepsis

Despite numerous advances in treating infections and disease, effective treatments for sepsis remain elusive. A new discovery published in the June 2013 issue of The FASEB Journal not only could help health care providers predict who is more and less likely to develop sepsis, but it also opens the doors to new therapies that actually address the root cause of the problem, rather than just managing the symptoms.

31 May 2013

Tibial nerve stimulation reduces symptoms of overactive bladder, research finds

Beaumont Health System research finds that symptoms of overactive bladder, or OAB, were reduced in those who received tibial nerve stimulation. The three-year results published in the June issue of The Journal of Urology show participants with urinary frequency, urgency and involuntary loss of urine maintained significant improvement in their symptoms.

31 May 2013

Targacept initiates TC-5214 Phase 2b clinical study in patients with OAB

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced the initiation of a Phase 2b clinical study of TC-5214 as a treatment for overactive bladder.

29 May 2013

Perrigo receives final approval for generic Sanctura XR

Perrigo Company today announced that it has received final approval for the generic version of Sanctura XR. Perrigo had previously prevailed in litigation at both the district and appellate levels. The product has begun shipping immediately.

29 May 2013

FDA approves iTrace for Blood Centers to assist in enhancing blood safety

iTrace for Blood Centers, (Version 1.0.924.0), the first application to use Radio Frequency Identification technology in blood establishments to assist in enhancing blood safety by preventing the release of unsuitable blood components, was cleared today by the U.S. Food and Drug Administration.

29 May 2013

Medical researchers identify genetic marker associated with sporadic breast cancer

Medical researchers at the University of Alberta have pinpointed a genetic marker for sporadic breast cancer - one of a handful identified to date in Caucasians.

29 May 2013

Physicists develop novel technique that can detect molecular variants

Harvard physicists have developed a novel technique that can detect molecular variants in chemical mixtures - greatly simplifying a process that is one of the most important, though time-consuming, processes in analytical chemistry.

23 May 2013

$Upsher-Smith completes USL255 Phase III clinical trial in patients with refractory POS$

Upsher-Smith completes USL255 Phase III clinical trial in patients with refractory POS

Upsher-Smith Laboratories, Inc. today announced the successful completion of its global Phase III clinical trial for USL255 (extended-release topiramate), an internally developed program for the management of epilepsy in adults, using the company's proprietary formulation technology.

23 May 2013

MemorialCare Health System receives 2013 Crimson Physician Partnership Award

MemorialCare Health System is one of two organizations chosen from more than 1,000 hospitals nationwide to receive the prestigious 2013 Crimson Physician Partnership Award presented by The Advisory Board at its Scottsdale, Arizona Summit.

22 May 2013

AIR2 trial: Alair BT System shows therapy benefits in adults with severe uncontrolled asthma

Five-year data from the Asthma Intervention Research 2 clinical trial presented today demonstrated that the Boston Scientific Corporation Alair Bronchial Thermoplasty System continues to show therapy benefits in adult patients with severe uncontrolled asthma.

22 May 2013

Frequency News and Research

Molecular subtyping can predict chemotherapy benefit in patients with colorectal cancer

Solid formulations of the recombinant anthrax vaccine: an interview with Dr Mark Carnegie-Brown, CEO, Glide Pharma

Zalicus advancing Z944 into further clinical development

PCORI awards $2.1M to USF college of nursing to study a new approach for cancer management

Experts from ProfNet are available to discuss hurricane preparedness and response

Twitter: A popular source for receiving and sharing new information about vaccines

UB researchers are developing a network of wireless body sensors

Fatigue and sleep have predictive value for sports performance

Surgeons use MarginProbe System to cut out breast cancer cells missed during initial lumpectomy

New avatar system could provide quick and effective therapy for schizophrenia

Discovery opens doors to new therapies for sepsis

Tibial nerve stimulation reduces symptoms of overactive bladder, research finds

Targacept initiates TC-5214 Phase 2b clinical study in patients with OAB

Perrigo receives final approval for generic Sanctura XR

FDA approves iTrace for Blood Centers to assist in enhancing blood safety

Medical researchers identify genetic marker associated with sporadic breast cancer

Physicists develop novel technique that can detect molecular variants

Upsher-Smith completes USL255 Phase III clinical trial in patients with refractory POS

MemorialCare Health System receives 2013 Crimson Physician Partnership Award

AIR2 trial: Alair BT System shows therapy benefits in adults with severe uncontrolled asthma

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News